ConCallIQ
Go Pro
ARTEMISMEDICARE Healthcare 15 May 2026

Artemis Medicare Services Ltd — Q4 FY26

Artemis Medicare delivered a strong Q4 FY26 with consolidated revenue of INR 279 crore (+16.4% YoY) and PAT of INR 30 crore (+32.1% YoY), driven by higher patient volumes in hig...

bullish high
Compare with...
Revenue ₹279 Cr +16.4%
EBITDA ₹59 Cr
PAT ₹30 Cr +32.1%
EBITDA Margin 21.3%
Duration 71 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Raipur ramp-up losses and margin dilution

Raipur hospital expected to incur INR 18-20 crore losses in FY27, potentially dragging consolidated EBITDA margin by 1-1.5%.

medium · management_commentary
R

Regulatory risk from medical device margin caps

Analyst raised concern about health ministry examining margin caps on medical devices (30-50% range); management downplayed but acknowledged uncertainty.

medium · analyst_question
R

International patient volatility from geopolitical events

March saw 15-18% dip in international patients due to West Asia war; recovery underway but risk remains.

low · management_commentary
R

Cash flow conversion below EBITDA

Cash flow from operations at ~60% of EBITDA; analyst noted lower conversion in H2, though management attributed to normal operations.

low · data_observation